Smoking in schizophrenia

Current Opinion in Psychiatry - Tập 32 Số 5 - Trang 402-408 - 2019
Marina Šagud1,2, Alma Mihaljević Peleš3,4, Nela Pivac5
1e-mail: [email protected]
2to Marina Sagud, Assistant Professor, Department of Psychiatry, University Hospital Centre Zagreb, Kišpatićeva 12, 10 000 Zagreb, Croatia. Tel: +38512388386
3Department of Psychiatry, University Hospital Centre Zagreb, Kispaticeva
4School of Medicine University of Zagreb
5Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Gopalaswamy, 1986, Smoking in chronic schizophrenia, Br J Psychiatry, 149, 523, 10.1192/S0007125000139856

Hughes, 1986, Prevalence of smoking among psychiatric outpatients, Am J Psychiatry, 143, 993, 10.1176/ajp.143.8.993

Dickerson, 2018, Cigarette smoking by patients with serious mental illness, 1999-2016: an increasing disparity, Psychiatr Serv, 69, 147, 10.1176/appi.ps.201700118

Kopczynska, 2019, Complement system biomarkers in first episode psychosis, Schizophr Res, 204, 16, 10.1016/j.schres.2017.12.012

Ohi, 2019, Smoking rates and number of cigarettes smoked per day in schizophrenia: a large cohort meta-analysis in a Japanese population, Int J Neuropsychopharmacol, 22, 19, 10.1093/ijnp/pyy061

Castillo-Sánchez, 2017, Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?, Clin Exp Hypertens, 39, 441, 10.1080/10641963.2016.1267200

Fond, 2018, Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort, Eur Arch Psychiatry Clin Neurosci, 268, 541, 10.1007/s00406-017-0847-1

Hirasawa-Fujita, 2017, Genetic variation of the mu opioid receptor (OPRM1) and dopamine D2 receptor (DRD2) is related to smoking differences in patients with schizophrenia but not bipolar disorder, Clin Schizophr Relat Psychoses, 11, 39, 10.3371/1935-1232-11.1.39

Nedic Erjavec, 2017, Cortisol in schizophrenia: no association with tobacco smoking, clinical symptoms or antipsychotic medication, Prog Neuropsychopharmacol Biol Psychiatry, 77, 228, 10.1016/j.pnpbp.2017.04.032

Dickerson, 2018, Natural cause mortality in persons with serious mental illness, Acta Psychiatr Scand, 137, 371, 10.1111/acps.12880

Sagud, 2018, Latent Toxoplasma Gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia, Compr Psychiatry, 82, 115, 10.1016/j.comppsych.2018.02.002

Hickling, 2018, Tobacco smoking and its association with cognition in first episode psychosis patients, Schizophr Res, 192, 269, 10.1016/j.schres.2017.04.018

Subramaniam, 2018, Prevalence, correlates and outcomes of insomnia in patients with first episode psychosis from a tertiary psychiatric institution in Singapore, Gen Hosp Psychiatry, 51, 15, 10.1016/j.genhosppsych.2017.11.009

Sagud, 2018, Haplotypic and genotypic association of catechol-O-methyltransferase rs4680 and rs4818 polymorphisms and treatment resistance in schizophrenia, Front Pharmacology, 9, 705, 10.3389/fphar.2018.00705

Sagud, 2018, Smoking in schizophrenia: an updated review, Psychiatr Danub, 30, 216

Sagud, 2018, Nicotine dependence in Croatian male inpatients with schizophrenia, BMC Psychiatry, 18, 18, 10.1186/s12888-018-1606-1

Ahnallen, 2012, The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia, Psychiatry Res, 196, 9, 10.1016/j.psychres.2011.09.011

Moran, 2018, Neural responses to smoking cues in schizophrenia, Schizophr Bull, 44, 525, 10.1093/schbul/sbx085

Lum, 2018, A systematic review of psychosocial barriers and facilitators to smoking cessation in people living with schizophrenia, Front Psychiatry, 9, 565, 10.3389/fpsyt.2018.00565

Ayerbe, 2018, Disparities in the management of cardiovascular risk factors in patients with psychiatric disorders: a systematic review and meta-analysis, Psychol Med, 48, 2693, 10.1017/S0033291718000302

Lucatch, 2018, Neurobiological determinants of tobacco smoking in schizophrenia, Front Psychiatry, 9, 672, 10.3389/fpsyt.2018.00672

Reginsson, 2018, Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction, Addict Biol, 23, 485, 10.1111/adb.12496

Rosecrans, 2018, Discriminative stimulus properties of S (-)-nicotine: ‘a drug for all seasons’, Curr Top Behav Neurosci, 39, 51, 10.1007/7854_2017_3

Wei, 2018, Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA, Cell Discov, 4, 60, 10.1038/s41421-018-0060-z

Keller, 2019, Comparison between dopaminergic and nondopaminergic neurons in the VTA following chronic nicotine exposure during pregnancy, Sci Rep, 9, 445, 10.1038/s41598-018-37098-1

2014, Biological insights from 108 schizophrenia-associated genetic loci., Nature, 511, 421, 10.1038/nature13595

Tobacco and Genetics Consortium, 2010, Genome-wide meta-analyses identify multiple loci associated with smoking behavior, Nat Genet, 42, 441, 10.1038/ng.571

Hartz, 2017, Association between substance use disorder and polygenic liability to schizophrenia, Biol Psychiatry, 82, 709, 10.1016/j.biopsych.2017.04.020

Carey, 2016, Associations between polygenic risk for psychiatric disorders and substance involvement, Front Genet, 7, 149, 10.3389/fgene.2016.00149

Kondratyev, 2018, Prediction of smoking by multiplex bisulfite PCR with long amplicons considering allele-specific effects on DNA methylation, Clin Epigenet, 10, 130, 10.1186/s13148-018-0565-1

Brown, 2018, An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: effects on glial cell line-derived neurotrophic factor (GDNF), Schizophr Res, 194, 107, 10.1016/j.schres.2017.03.024

Fletcher, 2018, Acquisition of nicotine self-administration in amphetamine and phencyclidine models of schizophrenia: a role for stress?, Schizophr Res, 194, 98, 10.1016/j.schres.2017.02.028

Koukouli, 2017, Nicotine reverses hypofrontality in animal models of addiction and schizophrenia, Nat Med, 23, 347, 10.1038/nm.4274

Waterhouse, 2018, Nicotine self-administration reverses cognitive deficits in a rat model for schizophrenia, Addict Biol, 23, 620, 10.1111/adb.12517

Boggs, 2018, Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the ‘self-medication’ hypothesis in schizophrenia, Schizophr Res, 194, 62, 10.1016/j.schres.2017.03.047

Vermeulen, 2018, Association between smoking behavior and cognitive functioning in patients with psychosis, siblings, and healthy control subjects: results from a prospective 6-year follow-up study, Am J Psychiatry, 175, 1121, 10.1176/appi.ajp.2018.18010069

Stramecki, 2018, Assessment of the association between cigarette smoking and cognitive performance in patients with schizophrenia-spectrum disorders: a case-control study, Front Psychiatry, 9, 642, 10.3389/fpsyt.2018.00642

Vanderhoof, 2018, Visuospatial and sensory integration tasks in patients with schizophrenia or schizoaffective disorder: relationship to body mass index and smoking, Front Psychiatry, 9, 473, 10.3389/fpsyt.2018.00473

Wang, 2018, Cognitive functions in smoking and nonsmoking patients with schizophrenia: a systematic review and meta-analysis of comparative studies, Psychiatry Res, 272, 155, 10.1016/j.psychres.2018.12.064

Kalmady, 2018, CHRFAM7A gene expression in schizophrenia: clinical correlates and the effect of antipsychotic treatment, J Neural Transm (Vienna, 125, 741, 10.1007/s00702-017-1833-5

Liu, 2018, Cigarette smoking and schizophrenia independently and reversibly altered intrinsic brain activity, Brain Imaging Behav, 12, 1457, 10.1007/s11682-017-9806-8

Huang, 2019, Psychopathology and extrapyramidal side effects in smoking and nonsmoking patients with schizophrenia: systematic review and meta-analysis of comparative studies, Prog Neuropsychopharmacol Biol Psychiatry, 92, 476, 10.1016/j.pnpbp.2019.02.011

Mallet, 2017, Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort, Prog Neuropsychopharmacol Biol Psychiatry, 79, 332, 10.1016/j.pnpbp.2017.06.026

Cassidy, 2018, Risk factors for suicidality in patients with schizophrenia: a systematic review, meta-analysis, and meta-regression of 96 studies, Schizophr Bull, 44, 787, 10.1093/schbul/sbx131

Rey, 2017, Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset, Eur Arch Psychiatry Clin Neurosci, 267, 567, 10.1007/s00406-017-0779-9

Wehring, 2017, Antipsychotic treatment and tobacco craving in people with schizophrenia, J Dual Diagn, 13, 36, 10.1080/15504263.2017.1288946

Gaudiano, 2018, Complex polypharmacy in patients with schizophrenia-spectrum disorders before a psychiatric hospitalization: prescribing patterns and associated clinical features, J Clin Psychopharmacol, 38, 180, 10.1097/JCP.0000000000000876

Scherf-Clavel, 2019, Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2, Int Clin Psychopharmacol, 34, 93, 10.1097/YIC.0000000000000250

Tveito, 2018, Age impacts olanzapine exposure differently during use of oral versus long-acting injectable formulations: an observational study including 8,288 patients, J Clin Psychopharmacol, 38, 570, 10.1097/JCP.0000000000000961

Li, 2018, In Vivo assessment of the effect of CYP1A2 inhibition and induction on pomalidomide pharmacokinetics in healthy subjects, J Clin Pharmacol, 58, 1295, 10.1002/jcph.1145

Ryu, 2019, Short-term regulation of the hepatic activities of cytochrome P450 and glutathione S-transferase by nose-only cigarette smoke exposure in mice, Food Chem Toxicol, 125, 182, 10.1016/j.fct.2018.12.035

Heres, 2014, Pharmacokinetics of olanzapine long-acting injection: the clinical perspective, Int Clin Psychopharmacol, 29, 299, 10.1097/YIC.0000000000000040

Mauri, 2018, Clinical pharmacokinetics of atypical antipsychotics: an update, Clin Pharmacokinet, 57, 1493, 10.1007/s40262-018-0664-3

Pauly, 2007, Tobacco-free electronic cigarettes and cigars deliver nicotine and generate concern, Tob Control, 16, 357, 10.1136/tc.2006.019687

Gentzke, 2019, Vital signs: tobacco product use among middle and high school students - United States, Morb Mortal Wkly Rep, 68, 157, 10.15585/mmwr.mm6806e1

Miller, 2017, Electronic cigarette use in patients with schizophrenia: prevalence and attitudes, Ann Clin Psychiatry, 29, 4

Khorassani, 2018, Supatherapeutic serum clozapine concentration after transition from traditional to electronic cigarettes, J Clin Psychopharmacol, 38, 391, 10.1097/JCP.0000000000000899

Kocar, 2018, Switching from tobacco smoking to electronic cigarettes and the impact on clozapine levels, J Clin Psychopharmacol, 38, 528, 10.1097/JCP.0000000000000948

Potvin, 2018, Increased connectivity between the nucleus accumbens and the default mode network in patients with schizophrenia during cigarette cravings, J Dual Diagn, 16, 1

Hswen, 2017, Exploring online communication about cigarette smoking among Twitter users who self-identify as having schizophrenia, Psychiatry Res, 257, 479, 10.1016/j.psychres.2017.08.002

Cather, 2017, Improved depressive symptoms in adults with schizophrenia during a smoking cessation attempt with varenicline and behavioral therapy, J Dual Diagn, 13, 168, 10.1080/15504263.2017.1319585

Ahmed, 2018, Efficacy and safety of varenicline for smoking cessation in schizophrenia: a meta-analysis, Front Psychiatry, 9, 428, 10.3389/fpsyt.2018.00428

Travaglini, 2017, Predictors of smoking cessation group treatment engagement among veterans with serious mental illness, Addict Behav, 75, 103, 10.1016/j.addbeh.2017.07.005

Shawen, 2018, Review of pharmacotherapy for smoking cessation in patients with schizophrenia, Ment Health Clin, 8, 78, 10.9740/mhc.2018.03.078